Logo-apb
Adv Pharm Bull. 2015;5(5): 629-636. doi: 10.15171/apb.2015.085
PMID: 26793608        PMCID: PMC4708033

Original Research

In Silico Analysis of HA2/Mx Chimera Peptide for Developing an Adjuvanted Vaccine to Induce Immune Responses Against Influenza Viruses

Sina Soleimani 1,2, Omid Madadgar 1, Shahla Shahsavandi 2 * , Homayoon Mahravani 2, Mohsen Lotfi 2

Cited by CrossRef: 4


1- Soleimani S, Shahsavandi S. Comparative Evaluation of Mx and Alum as Bio and Conventional Adjuvants in Inducing Immune Responses by Influenza DNA Vaccine. J Adv Med Biomed Res. 2021;29(137):331 [Crossref]
2- Jafari D, Malih S, Gomari M, Safari M, Jafari R, Farajollahi M. Designing a chimeric subunit vaccine for influenza virus, based on HA2, M2e and CTxB: a bioinformatics study. BMC Mol and Cell Biol. 2020;21(1) [Crossref]
3- Ghabeshi S, Ebrahimie E, Salimi V, Ghanizadeh A, Khodakhah F, Yavarian J, Norouzbabaei Z, Sasani F, Rezaie F, Azad T. Experimental direct-contact Transmission of Influenza A/H9N2 Virus in the Guinea Pig Model in Iran. Future Virol. 2020;15(5):277 [Crossref]
4- Soleimani S, Shahsavandi S, Maddadgar O. Improvement influenza HA2 DNA vaccine cellular and humoral immune responses with Mx bio adjuvant. Biologicals. 2017;46:6 [Crossref]